Skip to main content

Licensing

  • FDA approved 22 new drugs in lower-than-average 2016

    SILVER SPRING, Md. — The Food and Drug Administration’s Center for Drug Evaluation and Research’s number of new drug approvals came in low in 2016, according to the agency’s year-end review of the new therapies that passed regulatory muster. The number of drugs the FDA approved last year, 22, is less than half of the 45 approved in 2015 and lower than the average of the last 10 years of approvals, which is 29. 
     

  • Superior Court of Quebec rules in favor of Jean Coutu Group on franchise agreements

    VARENNES, Quebec — The Superior Court of Quebec ruled in favor of the Jean Coutu Group late December, the Canadian retailer announced Tuesday, ruling that the company's franchise agreements with pharmacist owners are not in violation of section 49 of the Code of Ethics of pharmacists of Quebec which prohibits pharmacists from sharing profits from the sale of medications or from their fees with a nonpharmacist.

  • Walgreens pilots vision care offering at Chicago flagship

    CHICAGO — Walgreens Boots Alliance is piloting a retail vision care center at one Walgreens location within its flagship Magnificent Mile store in the Wrigley Building here, the company recently revealed, taking what has been a successful page out of its U.K.-based Boots Pharmacy division and applying that strategy to the U.S. market.

  • Trump seeking critically important appointee for retailers

    In the Trump administration, retailers can expect a new head of the FDA, one of the 4,000 or so political appointees. 

    According to Forbes, the current FDA commissioner, Dr. Robert Califf, assumed the position only in February, so he has not really had time to make his mark.

    His predecessor, Dr. Margaret Hamburg, was there for seven years, however, and provides an exemplar of the kind of commissioner a Trump administration should avoid.

  • Rexall welcomes expansion of 13 vaccinations available through retail pharmacy in Ontario

    MISSISSAUGA, Ontario  — Rexall pharmacists in Ontario are now permitted to administer 13 more vaccinations that prevent shingles, hepatitis and cervical cancer, as well as several vaccines to people that are travelling overseas.

  • FDA to make hearing aids available OTC

    SILVER SPRING, Md. -- The U.S. Food and Drug Administration on Wednesday announced its commitment to considering a category of over-the-counter hearing aids that could deliver new, innovative and lower-cost products to millions of consumers.

    In addition, the agency issued a guidance document explaining that it does not intend to enforce the requirement that individuals 18 and up receive a medical evaluation or sign a waiver prior to purchasing most hearing aids.

  • H-E-B Specialty Pharmacy receives full accreditations

    SAN ANTONIO — H-E-B on Tuesday annoubnced its H-E-B Specialty Pharmacy division has received full accreditation to deliver specialized clinical services to patients with complex and chronic diseases in more than 260 H-E-B stores across the state of Texas.

  • FDA Office of New Drugs director Jenkins to retire

    FDA Office of New Drugs director to retire
     
    SILVER SPRING, Md. — The Food and Drug Administration’s director of the Office of New Drugs, Dr. John Jenkins, will be retiring from the agency, effective Jan. 6, 2017, Center for Drug Evaluation and Research director Dr. Janet Woodcock announced in an email to CDER staff Monday. 
     
X
This ad will auto-close in 10 seconds